Lindsay A. Rosenwald MD - 01 Jun 2021 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Award	$2,996	+1,297	+0.01%	$2.31	10,408,336	01 Jun 2021	Direct	F1
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Other	$0	+8,133	+0.08%	$0.000000	10,416,469	30 Sep 2021	Direct	F2
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Other	$0	+4,619	+0.04%	$0.000000	10,421,088	16 Nov 2021	Direct	F3
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Award	$3,025	+1,250	+0.01%	$2.42	10,422,338	01 Dec 2021	Direct	F1
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Award	$0	+1,102,986	+11%	$0.000000	11,525,324	01 Jan 2022	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
F2	The shares were issued as a dividend pursuant to the Dividend Payment and Exchange Agreement executed by Fortress Biotech, Inc. on March 31, 2021 in favor of the holders of Journey Medical Corporation's 8% Cumulative Convertible Class A Preferred Stock.
F3	The shares were issued upon the consummation of Journey Medical Corporation ("Journey's") initial public offering as a partial dividend pursuant to the Dividend Payment and Exchange Agreement executed by Fortress Biotech, Inc. on March 31, 2021 in favor of the holders of Journey's 8% Cumulative Convertible Class A Preferred Stock.
F4	The reporting person was granted 1,102,986 restricted shares pursuant to the issuer's Long-Term Incentive Plan on January 1, 2022.